These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 17898981)

  • 1. [Anticonvulsant treatment with zonisamide added to topiramate. A preliminary treatment analysis in 19 patients].
    Bös M; Bauer J
    Nervenarzt; 2007 Dec; 78(12):1425-9. PubMed ID: 17898981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Zonisamide as add-on treatment for focal epilepsies. An outcome analysis of 74 patients].
    Wellmer S; Wellmer J; Bauer J
    Nervenarzt; 2008 Dec; 79(12):1416, 1418-23. PubMed ID: 18633587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retention rate of zonisamide in intractable epilepsy.
    Nakken KO; Lindstrøm P; Andersen H
    Acta Neurol Scand; 2015 May; 131(5):268-74. PubMed ID: 25644477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cognitive impairments due to add-on therapy with topiramate].
    Huppertz HJ; Quiske A; Schulze-Bonhage A
    Nervenarzt; 2001 Apr; 72(4):275-80. PubMed ID: 11320862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion from valproic acid onto topiramate in adolescents and adults with epilepsy.
    Schreiner A; Stollhoff K; Ossig W; Unkelbach S; Lüer W; Bogdanow M; Schauble B;
    Acta Neurol Scand; 2009 May; 119(5):304-12. PubMed ID: 19133865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of topiramate and zonisamide on fMRI cognitive networks.
    Wandschneider B; Burdett J; Townsend L; Hill A; Thompson PJ; Duncan JS; Koepp MJ
    Neurology; 2017 Mar; 88(12):1165-1171. PubMed ID: 28213372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate, zonisamide and weight loss in children and adolescents prescribed psychiatric medications: A medical record review.
    Shapiro M; Reid A; Olsen B; Taasan M; McNamara J; Nguyen M
    Int J Psychiatry Med; 2016; 51(1):56-68. PubMed ID: 26681236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with topiramate dosing and serum levels in patients with epilepsy.
    Zanotta N; Raggi ME; Radice L; Degrate A; Bresolin N; Zucca C
    Seizure; 2006 Mar; 15(2):86-92. PubMed ID: 16406695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with zonisamide monotherapy and adjunctive therapy in children with epilepsy at a tertiary care referral center.
    Kim HL; Aldridge J; Rho JM
    J Child Neurol; 2005 Mar; 20(3):212-9. PubMed ID: 15832611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in cognition after introduction or withdrawal of zonisamide versus topiramate in epilepsy patients: A retrospective study using Bayes statistics.
    Meschede C; Witt JA; Brömling S; Moskau-Hartmann S; Rademacher M; Surges R; von Wrede R; Helmstaedter C
    Epilepsia; 2020 Jul; 61(7):1481-1490. PubMed ID: 32557579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of zonisamide as add-on in brain tumor-related epilepsy: preliminary report.
    Maschio M; Dinapoli L; Saveriano F; Pompili A; Carapella CM; Vidiri A; Jandolo B
    Acta Neurol Scand; 2009 Sep; 120(3):210-2. PubMed ID: 19719809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topiramate slow dose titration: improved efficacy and tolerability.
    Albsoul-Younes AM; Salem HA; Ajlouni SF; Al-Safi SA
    Pediatr Neurol; 2004 Nov; 31(5):349-52. PubMed ID: 15519117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topiramate: a prospective study on the relationship between concentration, dosage and adverse events in epileptic patients on combination therapy.
    Fröscher W; Schier KR; Hoffmann M; Meyer A; May TW; Rambeck B; Rösche J
    Epileptic Disord; 2005 Sep; 7(3):237-48. PubMed ID: 16162434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate in the treatment of severe myoclonic epilepsy in infancy.
    Nieto-Barrera M; Candau R; Nieto-Jimenez M; Correa A; del Portal LR
    Seizure; 2000 Dec; 9(8):590-4. PubMed ID: 11162758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topiramate in add-on therapy: results from an open-label, observational study.
    Krakow K; Lengler U; Rettig K; Schreiner A; Schauble B;
    Seizure; 2007 Oct; 16(7):593-600. PubMed ID: 17543544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of adjunctive topiramate therapy on seizure severity and health-related quality of life in patients with refractory epilepsy---a Canadian study.
    Baker GA; Currie NG; Light MJ; Schneiderman JH;
    Seizure; 2002 Jan; 11(1):6-15. PubMed ID: 11888254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of topiramate in childhood epilepsies].
    Adachi M; Oyazato Y; Nishiyama A; Murase M; Ishida A
    No To Hattatsu; 2010 Sep; 42(5):360-6. PubMed ID: 20845767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topiramate monotherapy as broad-spectrum antiepileptic drug in a naturalistic clinical setting.
    Guerrini R; Carpay J; Groselj J; van Oene J; Schreiner A; Lahaye M; Schwalen S;
    Seizure; 2005 Sep; 14(6):371-80. PubMed ID: 15961326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Seizure; 2008 Jan; 17(1):19-26. PubMed ID: 17618131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
    Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
    Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.